<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Population Health</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4F1F7316-D833-454F-9D84-B00045F83AB2"><gtr:id>4F1F7316-D833-454F-9D84-B00045F83AB2</gtr:id><gtr:firstName>Ramon</gtr:firstName><gtr:surname>Luengo-Fernandez</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802248"><gtr:id>6799C7A1-F95C-4E82-B79F-3F3F28DBAC46</gtr:id><gtr:title>Resource costs, health outcomes and cost-effectiveness in stroke care: Evidence from the Oxford Vascular Study</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802248</gtr:grantReference><gtr:abstractText>Cerebrovascular disorders, such as strokes, have high mortality, disability and healthcare costs. However, there is a lack of information on their costs and outcomes, information that is vital in order for the NHS to make accurate decisions. In my doctorate the costs and outcomes of stroke and transient ischaemic attacks (TIA), which are similar to very minor strokes, were estimated using data from a large study undertaken in Oxfordshire. My work also estimated the factors affecting patients? quality of life, disability, and costs to the NHS. Results showed that the prevention of further strokes decreased NHS costs and improved patients? quality of life. However, with a high risk of suffering another stroke shortly after TIA or minor stroke, prevention of further events needs to be timely in order to be effective. This is not the case, however, as patients tend to wait more than 14 days to be assessed and treated. The final part of my work evaluated the costs and outcomes of faster clinical assessment and treatment for such patients. This award would allow me to disseminate the results of my doctorate thesis.</gtr:abstractText><gtr:technicalSummary>Cerebrovascular disorders are a major source of mortality, neurological disability and health care resource use. Despite this, there is a lack of reliable information on their costs and outcomes, particularly in transient ischaemic attacks (TIA) and minor stroke. Such information is vital not only to inform decision about service provision both locally and nationally, but also to provide reliable estimates for use in cost-effectiveness analysis of prevention and treatment strategy. In my DPhil thesis the costs, quality of life and disability after a cerebrovascular event were estimated using data from a population-based incidence study undertaken in a population of over 91,000 individuals in Oxfordshire. With multiple and overlapping methods of case ascertainment, the Oxford Vascular Study (OXVASC) is the first-ever study of its kind. In order to inform the planning of service provision, especially for those patients considered as being at high risk of recurrent stroke, analyses undertaken as part of my DPhil also estimated the size and predictors of immediate and longer-term health care costs and outcomes of cerebrovascular disorders. With stroke having serious consequences in terms of mortality and disability, its prevention will have a huge impact on NHS resources. Data from OXVASC have shown that there is a very high risk of recurrent stroke during the first few days after a TIA or minor stroke. Therefore, the potential benefit of secondary stroke prevention relies on a short window of opportunity. However, with relatively low hospitalisation rates for TIA and minor stroke, this would entail faster access to outpatient specialist care, as approximately half of all these patients currently wait more than 14 days to be assessed and treated. As a result, using data from an observational study undertaken as part of OXVASC, the final part of my thesis evaluated the cost-effectiveness of faster clinical assessment and treatment after TIA or minor stroke. Using the work undertaken as part of my DPhil thesis the main aim of this project would be to disseminate its results, together with the methodology used to derive them. Furthermore, this project would allow a more in depth analysis in areas of the thesis were either due to word-limit or time constraints some of the outcome data collected was not examined.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>178819</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>Collaboration with Stroke Prevention Research Unit, University of Oxford</gtr:description><gtr:id>FB74102F-B2A7-4814-B330-E9AD3DC86F8D</gtr:id><gtr:impact>Publications listed under &amp;quot;Publications&amp;quot;.

The collaboration is multi-disciplinary, including consultants, statisticians, nurses, physiotherapists and other researchers.</gtr:impact><gtr:outcomeId>bKNWm5UGaYp-1</gtr:outcomeId><gtr:partnerContribution>I have been able to access all the data from the population-based cohort study, i.e. the Oxford Vascular Study, which is the basis of my research project. In addition, the director of the Stroke Prevention Research Unit, has been acting as an academic supervisor of my post-doctoral work.</gtr:partnerContribution><gtr:piContribution>I provide the health economic analysis for the Stroke Prevention Research Unit. I am responsible to assess the resource use and costs study patients incur and analyse all the long-term follow-up health outcome data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminar. Chile</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>BF77DE5F-1E3E-41AC-9B67-74BB406886BA</gtr:id><gtr:impact>I gave a seminar on the 'Investigaciones sobre econom&amp;iacute;a del c&amp;aacute;ncer y las enfermedades cr&amp;oacute;nicas (Research on the economics of cancer and chronic diseases). My talk was held as part of the &amp;quot;Elementos Para Una Pol&amp;iacute;tica P&amp;uacute;blica Sobre C&amp;aacute;ncer y Enfermedades Cronicas En Chile&amp;quot; seminar. Members included health professionals, decision makers, members of the public and other academics.

The seminar was attended by the Chancellor of the University, and the Dean of the Faculty of Medicine.</gtr:impact><gtr:outcomeId>PgvLwFi33Uk</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>Centre for Prevention of Stroke and Dementia</gtr:fundingRef><gtr:id>29439C3B-D5E9-46B7-8388-E4A64A379533</gtr:id><gtr:outcomeId>58c12986c35b13.98296079</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influence in NICE guidelines</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:guidelineTitle>NICE guidelines on stroke</gtr:guidelineTitle><gtr:id>87ACC5E6-06F5-44CF-83A0-C990426FC58A</gtr:id><gtr:impact>Work I undertook as part of the OXVASC study, assessing whether fast and urgent treatment of minor stroke and transient ischaemic attack reduced the probability of disability and NHS costs, lead, in part, to guidelines recommending urgent treatment for these patients.</gtr:impact><gtr:outcomeId>nVSEvQNDNAX</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This work constructs an algorithm to translate the modified Rankin
scale (mRS), which measures disability, into EQ-5D utility values, which measure quality of life.</gtr:description><gtr:id>5C859B65-9FC5-4368-83CA-ED6D0F8E52AC</gtr:id><gtr:impact>The algorithm has been used by researchers at the Univeristy of New York, University of Edinburgh and researchers in Poland. In addition when the algorithm methodology and results were presented at the Internation Health Economics Association (iHEA) congress it generated much research interest. 
In the coming months a command will be made available in STATA (a statistical package), so that researchers can use the algorithm directly.</gtr:impact><gtr:outcomeId>sNm36yfjvc4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Algorithm to convert disability data into quality of life.</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B7D51CBD-926C-43D4-A16F-714407259922</gtr:id><gtr:title>ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/444b825b7a38acf6f0df5a61d985b271"><gtr:id>444b825b7a38acf6f0df5a61d985b271</gtr:id><gtr:otherNames>Chandratheva A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>JTQ5kvAgH66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D2C393C-0C3C-4AB1-BD9B-4442D999DE34</gtr:id><gtr:title>Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e258641e97c25998626256e3adb72c9d"><gtr:id>e258641e97c25998626256e3adb72c9d</gtr:id><gtr:otherNames>Rivero-Arias O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>i5JupLGJcMN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47908718-7DCE-43FE-B0D0-F1788F768CE9</gtr:id><gtr:title>Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0f46d9bf2f7a117b7514b7c801763a8"><gtr:id>b0f46d9bf2f7a117b7514b7c801763a8</gtr:id><gtr:otherNames>Luengo-Fernandez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14792_22_24107865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BDF3B3C-37B1-4012-B948-92D5C9FBC63E</gtr:id><gtr:title>[Economic evaluation of healthcare technologies: an introduction for physicians].</gtr:title><gtr:parentPublicationTitle>Revista de neurologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c326041f6be6a32a2a75b55b62c02a72"><gtr:id>c326041f6be6a32a2a75b55b62c02a72</gtr:id><gtr:otherNames>Luengo-Fern?ndez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0210-0010</gtr:issn><gtr:outcomeId>BnM9ZQqMHve</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05ADFEC1-EC54-4825-A2A0-EF2F776FB2E0</gtr:id><gtr:title>Independent validation of the prolonged length of stay score.</gtr:title><gtr:parentPublicationTitle>Neuroepidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97d02da8a57000b3f24696268d12e937"><gtr:id>97d02da8a57000b3f24696268d12e937</gtr:id><gtr:otherNames>Koton S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0251-5350</gtr:issn><gtr:outcomeId>Mpt49pYq1vR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C301C9F-FD04-45C5-A9E4-724B9A4C6A72</gtr:id><gtr:title>Population-based study of acute- and long-term care costs after stroke in patients with AF.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0f46d9bf2f7a117b7514b7c801763a8"><gtr:id>b0f46d9bf2f7a117b7514b7c801763a8</gtr:id><gtr:otherNames>Luengo-Fernandez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>gwYdoNysZPt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2CFE672-95ED-4A38-9248-F23517C67CE1</gtr:id><gtr:title>Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC).</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0f46d9bf2f7a117b7514b7c801763a8"><gtr:id>b0f46d9bf2f7a117b7514b7c801763a8</gtr:id><gtr:otherNames>Luengo-Fernandez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pm_14792_22_23538179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2CDBE61-128D-4E2D-B4D1-B84B10201EA7</gtr:id><gtr:title>Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0f46d9bf2f7a117b7514b7c801763a8"><gtr:id>b0f46d9bf2f7a117b7514b7c801763a8</gtr:id><gtr:otherNames>Luengo-Fernandez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_14792_22_23920019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CDFAEAD-1010-4017-9239-42423A8E2651</gtr:id><gtr:title>Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae38b766646172e7d7167b59c2906af4"><gtr:id>ae38b766646172e7d7167b59c2906af4</gtr:id><gtr:otherNames>Paul NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_14792_22_23172867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8C98F68-2D46-4204-9040-03A598563A05</gtr:id><gtr:title>A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0f46d9bf2f7a117b7514b7c801763a8"><gtr:id>b0f46d9bf2f7a117b7514b7c801763a8</gtr:id><gtr:otherNames>Luengo-Fernandez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_14792_22_23160884</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802248</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>